Difficulty: Medium
Average Score: 90%
Practice
The drug of choice for treatment of methicillin-resistant Staphylococcus aureus infection is
Correct answer
B
Rationale
In the context of treating methicillin-resistant Staphylococcus aureus (MRSA) infections, the drug of choice is Vancomycin. Vancomycin is considered the first-line treatment for MRSA due to its effectiveness against this particular strain of bacteria. MRSA is resistant to many antibiotics, including methicillin and other penicillins, which is why drugs like cloxacillin (A) and erythromycin (C) are not effective in treating MRSA infections.
Amikacin (D) is an aminoglycoside antibiotic primarily used for treating severe bacterial infections, but it is not the drug of choice for MRSA infections.
In an educational context, understanding the appropriate antibiotic therapy for specific pathogens is crucial for healthcare professionals, especially in the era of increasing antibiotic resistance. Knowing the correct drug for treating MRSA, like Vancomycin in this case, can significantly impact patient outcomes by ensuring effective treatment and preventing the spread of resistant strains. This question highlights the importance of antimicrobial stewardship and evidence-based prescribing practices in clinical settings.
Amikacin (D) is an aminoglycoside antibiotic primarily used for treating severe bacterial infections, but it is not the drug of choice for MRSA infections.
In an educational context, understanding the appropriate antibiotic therapy for specific pathogens is crucial for healthcare professionals, especially in the era of increasing antibiotic resistance. Knowing the correct drug for treating MRSA, like Vancomycin in this case, can significantly impact patient outcomes by ensuring effective treatment and preventing the spread of resistant strains. This question highlights the importance of antimicrobial stewardship and evidence-based prescribing practices in clinical settings.